Clinical applications of optical coherence tomography in macular diseases

J. Fernando Arevalo; Aristides J. Mendoza; Carlos F. Fernandez; Juan G. Sanchez; A. Reinaldo

doi:10.1007/978-0-387-68987-6_11

Clinical applications of optical coherence tomography in macular diseases

J. Fernando Arevalo, Aristides J. Mendoza, Carlos F. Fernandez, Juan G. Sanchez, A. Reinaldo

Research output: Chapter in Book/Report/Conference proceeding › Chapter

4 Scopus citations

Abstract

Optical coherence tomography (OCT) is a new type of medical diagnostic imaging modality that performs high-resolution, micron-scale, cross-sectional tomography imaging of ocular structures in vitro and in vivo.¹ Researchers at Harvard, the Massachusetts Institute of Technology, and Tufts University developed this technology. The first commercial device for use in posterior segment structures became available in 1995 (Humphrey Instruments, Dublin, CA). The OCT image has an axial resolution of 10 μm, and this resolution is significantly higher than those achieved by the scanning laser ophthalmoscope, B-scan ultrasound, and ultrasound biomicroscopy (UBM), which have image resolutions of 300, 150, and 20 μm, respectively.²

Original language	English (US)
Title of host publication	Retinal Angiography and Optical Coherence Tomography
Publisher	Springer New York
Pages	223-238
Number of pages	16
ISBN (Print)	9780387689869
DOIs	https://doi.org/10.1007/978-0-387-68987-6_11
State	Published - Dec 1 2009
Externally published	Yes

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-0-387-68987-6_11

Cite this

@inbook{35cff4805ea14c2c8e63c86dfa004b80,

title = "Clinical applications of optical coherence tomography in macular diseases",

abstract = "Optical coherence tomography (OCT) is a new type of medical diagnostic imaging modality that performs high-resolution, micron-scale, cross-sectional tomography imaging of ocular structures in vitro and in vivo.1 Researchers at Harvard, the Massachusetts Institute of Technology, and Tufts University developed this technology. The first commercial device for use in posterior segment structures became available in 1995 (Humphrey Instruments, Dublin, CA). The OCT image has an axial resolution of 10 μm, and this resolution is significantly higher than those achieved by the scanning laser ophthalmoscope, B-scan ultrasound, and ultrasound biomicroscopy (UBM), which have image resolutions of 300, 150, and 20 μm, respectively.2",

author = "Arevalo, {J. Fernando} and Mendoza, {Aristides J.} and Fernandez, {Carlos F.} and Sanchez, {Juan G.} and A. Reinaldo",

year = "2009",

month = dec,

day = "1",

doi = "10.1007/978-0-387-68987-6_11",

language = "English (US)",

isbn = "9780387689869",

pages = "223--238",

booktitle = "Retinal Angiography and Optical Coherence Tomography",

publisher = "Springer New York",

}

TY - CHAP

T1 - Clinical applications of optical coherence tomography in macular diseases

AU - Arevalo, J. Fernando

AU - Mendoza, Aristides J.

AU - Fernandez, Carlos F.

AU - Sanchez, Juan G.

AU - Reinaldo, A.

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Optical coherence tomography (OCT) is a new type of medical diagnostic imaging modality that performs high-resolution, micron-scale, cross-sectional tomography imaging of ocular structures in vitro and in vivo.1 Researchers at Harvard, the Massachusetts Institute of Technology, and Tufts University developed this technology. The first commercial device for use in posterior segment structures became available in 1995 (Humphrey Instruments, Dublin, CA). The OCT image has an axial resolution of 10 μm, and this resolution is significantly higher than those achieved by the scanning laser ophthalmoscope, B-scan ultrasound, and ultrasound biomicroscopy (UBM), which have image resolutions of 300, 150, and 20 μm, respectively.2

AB - Optical coherence tomography (OCT) is a new type of medical diagnostic imaging modality that performs high-resolution, micron-scale, cross-sectional tomography imaging of ocular structures in vitro and in vivo.1 Researchers at Harvard, the Massachusetts Institute of Technology, and Tufts University developed this technology. The first commercial device for use in posterior segment structures became available in 1995 (Humphrey Instruments, Dublin, CA). The OCT image has an axial resolution of 10 μm, and this resolution is significantly higher than those achieved by the scanning laser ophthalmoscope, B-scan ultrasound, and ultrasound biomicroscopy (UBM), which have image resolutions of 300, 150, and 20 μm, respectively.2

UR - http://www.scopus.com/inward/record.url?scp=84865643106&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865643106&partnerID=8YFLogxK

U2 - 10.1007/978-0-387-68987-6_11

DO - 10.1007/978-0-387-68987-6_11

M3 - Chapter

AN - SCOPUS:84865643106

SN - 9780387689869

SP - 223

EP - 238

BT - Retinal Angiography and Optical Coherence Tomography

PB - Springer New York

ER -

Clinical applications of optical coherence tomography in macular diseases

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this